TRIPS Waiver Negotiators Reach Compromise, But Getting Consensus Is Uncertain

Proposed agreement limits waiver of certain patent rights to COVID-19 vaccines with potential to extend to COVID-19 diagnostics and therapeutics. India, South Africa, US and EU have agreed to the compromise but whether it becomes final depends on other WTO member countries.

WTO map
Four member countries of World Trade Organization reach agreement on TRIPS waiver and now must get consensus from 160 other members. • Source: Alamy

More from Legal & IP

More from Pink Sheet